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The Alternative Complement Pathway Seems
to be a UVA Sensor that Leads to Systemic
Immunosuppression
Michael P.F. Stapelberg1, Rohan B.H. Williams2, Scott N. Byrne1 and Gary M. Halliday1
UV wavebands in sunlight are immunomodulatory. About half the amount of UVA within a minimum erythemal
dose of sunlight is systemically immunosuppressive, whereas higher doses protect from UVB immunosuppres-
sion in mice. We have earlier shown that these responses to UVA are genetically restricted, as they occur in
C57BL/6 but not in Balb/c mice. We used gene set enrichment analysis of microarray data and real-time reverse
transcriptase (RT)-PCR confirmation to determine the molecular mechanisms associated with UVA immuno-
modulation. We found upregulation of mRNA for the alternative complement pathway. The core-enriched
genes complement component 3, properdin, and complement factor B were all activated by the
immunosuppressive dose of UVA only in UVA-responsive C57BL/6 but not in unresponsive BALB/c mice. This
therefore matched the genetic restriction and dose responsiveness of UVA immunosuppression. The immune-
protective higher UVA dose prevented UVB from downregulating chemokine receptor 7 and IL-12B, and
decreased IL-10, supporting the earlier identification of IL-12 and IL-10 in high-dose UVA protection from UVB
immunosuppression. Our study has identified activation of the alternative complement pathway as a trigger of
UVA-induced systemic immunosuppression and suggests that this pathway is likely to be an important sensor of
UVA-induced damage to the skin.
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INTRODUCTION
The UV wavebands contained in sunlight are the main cause
of skin cancer. Gene mutations and immunosuppression are
both important biological consequences of UV exposure that
lead to skin cancer (Halliday, 2005). UV wavebands in
sunlight are composed of approximately 5% UVB
(290–320nm) and 95% UVA (320–400nm), both of which
can cause gene mutations (Agar et al., 2004) and immuno-
suppression (Poon et al., 2005) in humans.
UVA-induced molecular triggers for immunosuppression
have received little research attention. Unlike UVB, which
has a linear dose–response relationship with immunosuppres-
sion, UVA causes a complex bell-shaped dose–response
curve. Therefore, the molecular signals initiated by UVA that
lead to immunosuppression are also likely to have a
nonlinear dose response. We have earlier shown that three
consecutive exposures of C57BL/6 mice to 1,700mJ cm2
UVA causes systemic immunosuppression on sensitization at
a distal non-irradiated site, whereas twice this dose does not
induce immunosuppression. These dose-related effects of
UVA are genetically restricted, as they occurred in C57BL/6
but not in Balb/c mice. Furthermore, exposure of C57BL/6
mice to solar-simulated UV (ssUV) consisting of an immu-
nosuppressive UVB dose combined with the higher non-
suppressive dose of UVA does not cause immunosuppression
(Byrne et al., 2002). This is consistent with studies that high-
dose UVA protects mice from UVB immunosuppression
(Reeve et al., 1998). Although UVA does not contribute
substantially to the erythemal or oedemal components of
sunburn, the immunosuppressive dose of UVA in mice and
humans (Poon et al., 2005) is about half of what would be
delivered to pale skinned Caucasians receiving a dose of
sunlight sufficient to cause barely detectable sunburn
(minimum erythemal dose). Therefore, these immunosup-
pressive UVA doses are within the range received by humans
during normal daily activities.
UVA must therefore affect different molecular mechanisms
at different doses to have this complex affect on immunity. As
there are no known UVA-induced molecular responses to
explain immunosuppression, we took a global approach of
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microarray analysis and validation with quantitative real-time
reverse transcriptase (RT)-PCR combined with the power of
the genetic association of the UVA dose response in C57BL/6
but not in Balb/c mice to determine the most prominent
molecular pathway changes that were associated with UVA
immunosuppression.
RESULTS
All raw microarray data are available at Gene Expression
Omnibus (GEO) with accession GSE15618.
UVA causes systemic immunosuppression in C57BL/6 but not in
Balb/c mice with a bell-shaped dose response
UVA systemically suppressed the induction of primary
immunity in C57BL/6 mice at a lower (1,750mJ cm2) but
not higher (3,500mJ cm2) dose (Figure 1a). The contact
hypersensitivity (CHS) results also showed that UVA did not
modulate immunity in Balb/c mice over this dose range
(Figure 1b). We further clarified the immunomodulatory
effects of UVA by combining the higher dose with an
immunosuppressive UVB dose (285mJ cm2) chosen so that
this mix of UVA and UVB was a good mimic of sunlight
(ssUV). UVB suppressed the induction of CHS in both mouse
strains. However, the CHS response of C57BL/6 mice was
unaffected by this dose of UVB when combined with the
higher dose of UVA to produce ssUV (Figure 1a). Therefore,
this higher dose of UVA protected C57BL/6 mice from the
immunosuppressive effects of UVB. In contrast, ssUV
suppressed CHS in Balb/c mice (Figure 1b), showing that
the higher UVA dose did not protect from UVB in this mouse
strain. Therefore, UVA modulates immunity in C57BL/6 but
not in Balb/c mice with a complex dose response. It
suppressed immunity at the lower but not the higher dose.
The higher dose is not immunologically inert, as it protects
from UVB-induced suppression.
The immunosuppressive, but not the higher UVA dose activates
the alternative complement pathway
To search for signaling pathways likely to be involved in
UVA-induced immunosuppression, we used microarrays
with gene set enrichment analysis (GSEA). This analysis
searches for co-ordinated changes in whole pathways and
therefore is more robust than searching for changes in single
genes and also enables a stringent statistical analysis to be
carried out. Enriched pathways (Po0.05 and false discovery
rate (FDR)o0.05) were identified for irradiated C57BL/6 and
Balb/c mice compared with unirradiated control mice. Our
search strategy, on the basis of the CHS responses described
above was that a pathway likely to be involved in UVA
immunosuppression would be altered by the lower, but not
the higher, UVA dose in C57BL/6 but not in Balb/c mice. This
would match the genetic restriction and dose response. All
statistically significant enriched pathways are listed in
Table 1. Furthermore, for each enriched pathway listed in
Table 1, core-enriched genes were identified using GSEA.
Core-enriched genes contribute most to the enrichment score
of the pathway. The core-enriched genes chosen for
confirmation by real-time PCR are also listed in Table 1.
The 50 most up- and downregulated pathways for each UV
spectra, dose and mouse strain are shown in supplementary
tables 1–12 to provide additional information.
In C57BL/6 mice, only the alternative complement path-
way (P¼0.001, FDR¼0.035) was significantly upregulated.
No pathways were downregulated. Neither this, nor any
other pathway was altered by the lower UVA dose in Balb/c
mice, and the higher UVA dose did not modulate this
pathway in C57BL/6 mice. To confirm the association of the
alternative complement pathway with UVA-induced immu-
nosuppression, a selected number of core-enriched genes
were examined in a series of different skin samples by
quantitative real-time RT-PCR (Figure 2). In C57BL/6 mouse
skin irradiated with the lower UVA dose, real-time RT-PCR
showed significant upregulation of the alternative comple-
ment pathway genes C3, complement factor B (CFB) and
properdin. These genes were not altered by the higher UVA
dose, UVB, or ssUV (which contained the higher UVA dose).
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Figure 1. UVA causes immunosuppression at the lower and not higher dose
tested in C57BL/6 but not in Balb/c mice. Contact hypersensitivity (CHS) was
assessed in (a) C57BL/6 and (b) Balb/c mice by measuring ear swelling 24
hours after challenge, which was 7 days after sensitization on the abdomen.
Mice had been irradiated on the dorsal trunk for 3 consecutive days with
1,750 (lower UVA) or 3,500 (higher UVA) mJ cm2 UVA, or with 285mJ cm2
UVB or this UVB dose combined with the higher UVA to produce solar-
simulated UV (ssUV). Irritant controls (ear swelling of unsensitized mice) were
subtracted from sensitized mice. For each CHS experiment the ear swelling
for each mouse that was irradiated with UV was normalized to the mean of
the control group that did not receive UV irradiation to remove inter-
experimental variation in magnitude of the control response. Each experiment
was repeated thrice and normalized values were pooled. The mean and SEM
of normalized values are shown. The total number of mice for each group is
shown (n). An unpaired student’s t-test was used for statistical analysis
compared with the unirradiated group.
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Table 1. Enriched pathways for lower and higher UVA, UVB, and ssUV
Enriched pathway Po0.05 FDR q-value P-value Enriched phenotype1 Strain Genes2
Alternative complement 0.035 0.001 Increased by lower UVA C57BL/6 C33, CFB3, PFC3
Inflammatory response 0.014 0.001 Increased by higher UVA C57BL/6 CD803, CD86
Classical complement 0.039 0.001 Increased by higher UVA C57BL/6 C1QA3, C1QB
Cytokine 0.010 0.001 Decreased by higher UVA C57BL/6 IL3, IL9
Cytokine 0.007 0.001 Decreased by higher UVA Balb/c IL3, IL9
b alanine metabolism 0.005 0.001 Increased by UVB C57BL/6 ALDH23, ALDH9A13
Propanoate metabolism 0.011 0.001 Increased by UVB C57BL/6 ALDH23, ALDH9A13
Valine, leucine, and isoleucine
degradation
0.012 0.001 Increased by UVB C57BL/6 ALDH23, ALDH9A13
nkt 0.052 0.003 Decreased by UVB C57BL/6 CCR73, IFNg3
IL12 0.023 0.005 Increased by ssUV C57BL/6 IL12B3, IL12RB2
IL10 0.047 0.001 Decreased by ssUV C57BL/6 IL63, IL103
ALDH2, aldehyde dehydrogenase 2 family; ALDH9A1, aldehyde dehydrogenase 9 family, member A1; CCR7, chemokine receptor 7; CFB, complement
factor B; FDR, false discovery rate; PFC, properdin; RT, reverse transcriptase.
1Increased or decreased by UV compared with unirradiated control.
2Core-enriched and associated genes for enriched pathways.
3Genes selected for real-time RT-PCR.
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Figure 2. Confirmation of quantitative gene expression of core enriched and associated genes using real-time reverse transcriptase (RT)-PCR. For statistical
analysis a Kolmogorov–Smirnoff test first determined that the data obtained from the six biological replicates were normally distributed. An unpaired student’s
t-test was then used for statistical analysis * Po0.05, ** Po0.01 compared with the unirradiated control mice (0 UV). Bar graphs represent meansþ SEM of six
biological replicates for lower and higher UVA, UVB, and ssUV doses. ALDH2, aldehyde dehydrogenase 2 family; ALDH9A1, aldehyde dehydrogenase 9
family, member A1; CCR7, chemokine receptor 7; CFB, complement factor B; PFC, properdin.
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In UVA unresponsive Balb/c mice, none of these genes were
altered by low-dose UVA, and only C3 was significantly
downregulated by the higher UVA dose (results not pre-
sented). Therefore, increased expression of alternative com-
plement pathway genes correlated with the genetic restriction
and dose response for UVA-induced immunosuppression.
Higher dose of immunoprotective UVA associated with
normalization of IL-12B and CCR7, and decreased IL-10
To examine the possible immunomodulatory signals
activated by the higher immunoprotective dose of UVA, this
dose was compared with unirradiated mice, and the
combination of this UVA dose with UVB (ssUV) was
contrasted to UVB-irradiated mice.
In C57BL/6, but not in Balb/c mice, the inflammatory
response (P¼ 0.001, FDR¼0.014) and classical complement
(P¼0.001, FDR¼0.039) pathways were significantly upre-
gulated. The cytokine pathway was significantly down-
regulated in both mouse strains. As C57BL/6, but not
Balb/c mice were modulated over this UVA dose range, this
pathway was regarded as not being involved in immuno-
modulation and was not considered further.
To determine the pathways involved in higher dose UVA
protection from UVB, relative effects of UVB compared with
ssUV is more insightful to determine the UVB effects
modulated by addition of higher dose UVA. In C57BL/6
mice, the b alanine metabolism (P¼0.001, FDR¼0.005),
propanoate metabolism (P¼0.001, FDR¼ 0.011), and va-
line, leucine, and isoleucine degradation (P¼0.001,
FDR¼0.012) pathways were significantly upregulated. No
pathways were downregulated by UVB using the qo0.05
FDR cut-off. However, the nkt pathway (P¼0.003,
FDR¼0.052) was very close to the qo0.05 FDR cut-off
and was therefore considered further, as these criteria have
earlier been suggested to be worthy of further study
(Subramanian et al., 2005). In C57BL/6 mice exposed to
ssUV, only the IL-12 pathway was upregulated (P¼0.005,
FDR¼0.023) and the IL-10 (P¼0.001, FDR¼ 0.047) path-
way was downregulated (Table 1). These changes were not
induced by ssUV in Balb/c mice.
After this screen by pathway analysis of microarray data,
core-enriched genes identified in these pathways (Table 1)
were compared in a different set of skin from irradiated mice
by real-time RT-PCR. The higher UVA dose significantly
upregulated the inflammatory response pathway CD80 and
classical complement pathway C1QA core-enriched genes,
confirming the microarray GSEA. Although these genes were
not altered in Balb/c mice (data not shown), they were not
increased by the same UVA dose when combined with UVB
(ssUV), indicating, not surprisingly, that the combined effects
of these wavebands differ from the summation of each
waveband alone. Therefore, these changes are unlikely to be
important for higher dose UVA protection from UVB.
In C57BL/6 mice irradiated with UVB, significant down-
regulation of the nkt pathway core-enriched gene chemokine
receptor 7 (CCR7) determined by real-time RT-PCR con-
firmed the microarray data. The core-enriched genes for the
remaining pathways identified by GSEA (aldehyde dehydro-
genase 2 family and aldehyde dehydrogenase 9 family,
member A1) were not confirmed by RT-PCR. In C57BL/6
mice irradiated with ssUV, GSEA identified the IL-12 pathway
as being increased and the IL-10 pathway as being decreased.
Real-time RT-PCR did not confirm the ssUV-induced increase
in the IL-12B gene, as it was not significantly different to the
unirradiated group. However, in comparison with the UVB
dose, the IL-12 pathway gene IL-12B was no longer down-
regulated. Therefore, the UVA component of ssUV inhibited
the downregulation of IL-12B caused by UVB. Furthermore,
IL-10 was confirmed to be significantly downregulated by
ssUV but not by UVB in C57BL/6 but not in Balb/c mice (data
not shown for Balb/c mice). In summary these data show that
genes upregulated by the immunoprotective UVA dose alone
do not predict differences between the effects of UVB and
ssUV. They further indicate that prevention of UVB-induced
downregulation of CCR7 and IL-12B along with reduced
expression of IL-10 seem to correlate with higher dose UVA
protection from UVB-induced immunosuppression.
DISCUSSION
In this study, we used pathway analysis of microarray data
and quantitative real-time RT-PCR to identify molecular
mechanisms associated with systemic UVA immunosuppres-
sion. The CHS results in this study were consistent with
earlier findings (Byrne et al., 2002). UVA was immunosup-
pressive at a lower, but not higher, dose in C57BL/6 but not in
Balb/c mice. The higher UVA was not immunologically inert,
but protected from UVB-induced immunosuppression with
the same genetic association. We determined that the
alternative complement pathway responds to UVA and may
be a key trigger of UVA-induced immunosuppression. This is
because mRNA for genes in this pathway was found to be
upregulated by the immunosuppressive dose of UVA, but not
by the higher immunoprotective dose, nor by UVB alone or
combined with the higher protective UVA dose. This
upregulation of alternative complement occurred in respon-
sive C57BL/6 but not in unresponsive Balb/c mice, and
therefore was associated with the genetic restriction, dose
and waveband response relationship with UVA immunosup-
pression. Our data also showed that immunoprotection by
the higher UVA dose was allied with the prevention of UVB-
induced depletion of CCR7 and IL-12B, and a reduction in
IL-10 mRNA.
Three pathways lead to complement activation, the
classical, lectin, and alternative pathways. All three pathways
result in the production of C3 and a subsequent activation of
the final lytic pathway and membrane attack complex. The
alternative pathway is unique in complement activation, in
that it functions as an amplification loop activating itself with
its own product, C3b (Schreiber and Muller-Eberhard, 1978;
Schreiber et al., 1978). Complement components C3 and
CFB are central to the alternative pathway, as after activation
they become key constituents of the serine protease C3bBb
(Isenman and Cooper, 1981). C3bBb cleaves C3 molecules
producing C3b (Schreiber and Muller-Eberhard, 1978;
Schreiber et al., 1978). The cleavage of C3 in the alternative
pathway is promoted by properdin (Fearon and Austen,
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1975a, b). Properdin protects C3bBb and C3b bi-products
including iC3b from degradation, resulting in an accumula-
tion of C3b and iC3b in tissue. The epidermis of normal skin
is a rich source of components of the alternative complement
pathway including C3 and CFB (Dovezenski et al., 1992). C3-
associated molecules of the alternative pathway have also
been observed in the basement membrane zone of the
epidermis (Yoshida et al., 1998). Studies have shown that
epidermally derived cytokines including IL-6 enhance the
synthesis of alternate pathway C3 and CFB (Pasch et al.,
2000; Stapp et al., 2005). In this respect, it is interesting that
the suppressive UVA, but not the higher dose, increased IL-6
expression. Therefore, induction of IL-6 could contribute to
UVA-induced immunosuppression by augmenting or initiat-
ing activation of the alternative complement pathway.
It has not been suggested earlier that the alternative
complement pathway is involved in systemic immunosup-
pression caused by UVA exposure of the skin. However, UVB
causes deposition of C3 and later components of the
membrane attack complex in the skin (Rauterberg et al.,
1993), and UVB-induced activation of C3 to produce iC3b
has been shown to be important for local immunosuppression
(Hammerberg et al., 1998). Whether the iC3b involved in
UVB-induced local immunosuppression was a product of
the classical, lectin, or alternative pathways was not clear,
but iC3b binding to its receptor CD11b on macrophages
infiltrating UVB-exposed skin was identified as being
important for local UVB-induced immunosuppression (Ham-
merberg et al., 1998). Neutralization of C3 with soluble
complement receptor 1 prevented UVB-induced local
immunosuppression and reduced infiltration by CD11bþ
macrophages; in addition, immunosuppression did not occur
in C3 knockout mice. This study differed to ours in a number
of ways. A dose of UVB was used that induced local but not
systemic immunosuppression, and both iC3b and infiltrating
CD11bþ macrophages were required at the site of antigen
exposure. In our study, activation of the alternative comple-
ment pathway in UVA-irradiated skin was at a different site to
antigen exposure, and therefore interactions between com-
plement components, any inflammatory cells, and antigen
could not have occurred. In addition, the UVA irradiation
regime used in these studies systemically suppresses primary
but not secondary immunity and therefore does not induce
tolerance (Byrne et al., 2002). This contrasts with the studies
described above that showed a role for C3 using a UVB
irradiation dose that caused locally induced tolerance
(Hammerberg et al., 1998).Therefore, the mechanism by
which the alternative complement pathway leads to
systemic UVA immunosuppression is likely to be different
to what was described by Hammerberg et al. Nevertheless,
our study supports an important regulatory role for
complement in responses of the skin immune system to UV
radiation.
It is unclear how the immunosuppressive, but not the
higher, dose of UVA could induce expression of the
alternative complement pathway. This pathway has multiple
positive and negative regulators. It is possible that the lower
UVA dose could activate one of the positive regulators and
the higher UVA dose activates one of the inhibitors, or the
lower UVA dose could relieve the pathway of one of its
inhibitory mechanisms, enabling it to become activated. For
example, properdin binding to lipopolysaccharide activates
the alternative complement pathway, and the yeast cell wall
component zymosan can activate alternative complement
through a mechanism dependent on CFB (Kimura et al.,
2008). These complement components therefore seem to be
pattern recognition molecules. UVA is a potent oxidizer of
lipids and other cellular macromolecules (Halliday, 2005),
and it is possible that alternative complement components
may recognize and be activated by these UVA-altered cell
structures. It is unlikely that activation of the membrane-
attack complex is required for the alternative complement
pathway to trigger UVA immunosuppression, as these later
steps in the complement pathway, components C4–C9, are
part of the classical pathway, which were not found to be
involved in UVA immunosuppression in our study. It is more
likely that one of the alternative complement proteins acts as
a sensor of UVA-induced damage by binding to an unknown
cell surface receptor or triggering a sequence of events
culminating in systemic immunosuppression. Elucidation of
these details will require extensive biochemical and func-
tional characterization.
Higher dose UVA protection from UVB immunosuppres-
sion was associated with UVA prevention of UVB-induced
reduction in CCR7 and IL-12B, and with a reduction in IL-10
expression. Activated dendritic cells, including Langerhans
cells, express the CCR7 (Ohl et al., 2004). UV has earlier
been shown to impair the induction of CCR7 on dendritic
cells during maturation, thus preventing their migration to
draining lymph nodes (Mittelbrunn et al., 2005). In these
experiments, antigen was applied to normal unirradiated skin
and dendritic cells function and numbers in the draining
lymph nodes have been found not to be altered during
systemic immunosuppression (Byrne and Halliday, 2005;
Gorman et al., 2005). It is therefore unlikely that high-dose
UVA protection of CCR7 expression in the irradiated skin
would prevent systemic immunosuppression.
A UVA dose about 10-fold higher than what was used in
these studies, that has previously been shown to protect from
systemic UVB immunosuppression in Skh:HR-1 hairless
mice, has been shown to abrogate UVB-enhanced expression
of IL-10, and to increase IL-12 protein production (Shen et al.,
1999). This study further showed that IFN-g was initially
upregulated by high-dose UVA, which then lead to an
increased expression of IL-12. The genome-wide expression
analysis in this study, using different mouse strains and a
lower UVA dose supports this earlier study by Shen et al. that
high-dose UVA inhibition of IL-10 and prevention of IL-12
reduction by UVB are likely to be important mediators of
UVA immunoprotection. This is also consistent with earlier
studies that UVB-induced production of IL-10 contributes to
UV immunosuppression (Nishigori et al., 1996) and that
IL-12 can reverse UVB-induced immunosuppression by
blocking IL-10 secretion (Schwarz et al., 1996). Macrophages
infiltrating UVB-exposed skin migrate to lymph nodes
in response to contact sensitization in which they produce
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IL-10, and UV also reduces IL-12 production by lymph node
CD11cþ cells in response to contact sensitization (Toichi
et al., 2008). Thus, inflammatory cells and keratinocytes
(Shen et al., 1999) show a similar pattern of IL-12 and IL-10
production that regulates responses to UV. We examined skin
after exposure to low doses of UVA, which does not cause
observable inflammation and therefore the cytokines and
complement components were likely to have been produced
by resident skin cells.
In summary, our studies have identified that the alternative
complement pathway seems to be a sensor of UVA-induced
damage to the skin, leading to systemic immunosuppression.
The immunosuppressive dose of UVA is only half the amount
contained in a minimum erythemal dose of sunlight. There-
fore, this UVA dose can be achieved by sunlight exposure
during normal daily activities and is physiologically relevant
for a large proportion of humans. Alternative complement is a
complex pathway with multiple proteins that could be
activated or inhibited by recognition of UVA-altered mole-
cular structures in the skin and may be responsible for the
complex bell-shaped dose response for UVA immunosup-
pression. This was the only pathway identified by our global
genome approach and pathway analysis to be associated with
UVA-induced immunosuppression. This approach was lim-
ited to detection of events leading to a change in mRNA
expression, and therefore other events that we did not detect
are likely to be involved. Our studies also confirmed earlier
observations that high-dose UVA protection from UVB-
induced immunosuppression is mediated, at least in part,
by protection of IL-12 and a reduction in IL-10. Complement
seems to be an important trigger of UV immunosuppression
and requires further research.
MATERIALS AND METHODS
Mice
Female C57BL/6 and Balb/c mice aged 8–9 weeks at the start of
irradiations were used for these experiments (Animal Resource
Centre, Perth, WA, Australia), which were conducted with the
approval of the University of Sydney animal ethics committee.
Before each irradiation, the dorsal trunk was shaved and the mice
were then allowed to rest for 24 hours. Mice to be irradiated were
then placed in an animal-restraining cage covered with a quartz
glass lid. All irradiation times wereo2 minutes and air-conditioning
was used to ensure that the mouse body temperature did not increase
during irradiation. Single irradiation for microarray and RT-PCR
experiments and three irradiations on consecutive days for contact
sensitivity experiments were given to each mouse and all irradiations
were always carried out at the same time of the day.
UV source
A 1,000W xenon arc solar simulator (Oriel, Stratford, CT) with two
dichroic mirrors that allow wavelengths between 200 and 400 nm to
pass through were used with a filter that blocks UVB to produce a
UVA spectrum. For ssUV and UVB, filters were used to attenuate the
visible and infrared wavelengths and remove UVC (o290nm) so
that it simulated sunlight (ssUV), or comprised predominantly UVB.
The spectra have earlier been described (Byrne et al., 2002). The
intensity (mWcm2) of the UVA, UVB, and ssUV output was
measured regularly using a radiometer (Solar Light Company, PA),
which had been calibrated against the source with an OL-754
spectroradiometer (Optronics Laboratories, Orlando, FL), and the
timing of UV exposure was adjusted using an automated timing
device to deliver consistent UV doses. The spectral output was
regularly measured using the OL-754 spectroradiometer calibrated
against standard lamps. The UVA doses were 1,750 and
3,500mJ cm2, respectively, and for simplicity will be referred to
as the lower and higher UVA doses. The UVB and ssUV doses were
285 and 3,860mJ cm2, respectively, (comprising 285 UVB with
3,575mJ cm2 UVA) and for simplicity will be referred to as the UVB
and ssUV doses. The UV doses used in this study are physiological
and representative of typical human sunlight exposure. The UVB and
higher UVA doses are the amounts in sunlight that would cause
barely detectable sunburn. The ssUV dose is the same amount of
UVB combined with UVA to approximate the solar spectrum and
give a barely detectable sunburn.
Contact hypersensitivity response
The experimental design and protocol for all CHS experiments was
as described (Byrne et al., 2002). Mouse abdomens were shaved and
sensitized with a 50 ml epicutaneous application of 2% (w/v)
oxazolone (4-ethoxymethylene-2-pheyl-2-oxazolin-5-one; Sigma,
St Louis, MN) in acetone 3 days after the last UVA, UVB, and ssUV
irradiation, which had been on the dorsal trunk. After 7 days, the
mouse’s ears were challenged topically with 10 ml of 2% (w/v)
oxazolone in acetone per ear. Changes in ear thickness were then
measured using micrometer calipers (Interapid, Tesa, Bergdietikon
Switzerland).
RNA isolation for the microarray study and real-time RT-PCR
At 24 hours after UVA, UVB, and ssUV irradiation a 1-cm2 uniform
section of skin was excised from the dorsal surface of irradiated and
control mice. Total RNA was then extracted from the whole skin
using TRIzol reagent (Gibco Invitrogen Life Technologies, Carlsbad,
CA) according to the manufacturer’s instructions, purified, DNase
treated, and reverse transcribed into cDNA. For the microarray
study, a direct incorporation of Cyanine 3-dCTP and Cyanine 5-
dCTP fluorescent dyes (Perkin Elmer Life Sciences, Inc. Boston, MA)
was used for cDNA synthesis. For each UV dose, a reference design
was used to compare an unirradiated control against an irradiated
sample. Microarray experiments used compugen 22k mouse
oligonucleotide microarray slides (The Clive and Vera Ramaciotti
Centre for Gene Function Analysis, Sydney, Australia (http://www.
ramaciotti.unsw.edu.au) and were replicated six times for each UV
dose. A fluorescent dye swap was done for each alternate
hybridization to reduce systematic dye bias of incorporated
fluorescent dyes.
Microarray analysis
The first component of the microarray analysis was done using the R
software package Linear Models for Microarray Data (Bioconductor)
(Wettenhall and Smyth, 2004) and involved no background
correction, within-array print-tip loess normalization, followed by
scale normalization for each unirradiated control and UV-irradiated
group (Yang et al., 2002).
To determine the biological pathways likely to be playing a role
in UVA immunomodulation, UVB immunosuppression and the
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interaction between UVB and UVA in ssUV, all genes expressed on
the microarrays from each unirradiated control and UV-irradiated
group were analyzed using GSEA (Subramanian et al., 2005).
From each unirradiated control versus UV-irradiated group
comparison, we used normalized red and green channel data in
identifying pathways that were differentially expressed using GSEA.
GSEA was carried out as described earlier by Subramanian et al.,
2005 using a total of 489 gene sets containing genes whose products
are involved in specific metabolic and signaling pathways (Sub-
ramanian et al., 2005). We used the default setting signal to noise
ranking metric in GSEA to rank genes. The statistical significance
(P-value) of each pathway was estimated by using phenotype-based
permutation analysis using 1,000 random permutations. We chose
pathways with a significant enrichment score (Po0.05) that had
been adjusted for multiple comparisons using the FDR (qo0.05; or
very close to qo0.05) for further interpretation. The FDR is a
quantity that describes, for a set of tests that are called significant at
or above a given level, what proportion of them are likely to be false-
positive findings (Storey and Tibshirani, 2003). For each unirradiated
control versus UV-irradiated comparison, GSEA identified signifi-
cantly enriched pathways that were either up- or downregulated by
UVA, UVB, and ssUV. Each of these significantly enriched pathways
contained core-enriched genes. These genes contribute most to the
enrichment score of the pathway, and therefore are most likely to
participate in a biological response.
To determine which pathways were associated with the dose-
related effects of UVA on immunomodulation in C57BL/6 mice, a
cross-comparison was made between statistically enriched results in
C57BL/6 and Balb/c mice. Any pathways that had a significant
enrichment score (Po0.05) and that met the FDR qo0.05 criterion
in both strains were regarded as unlikely to be associated with effects
of UVA on immunomodulation. The remaining pathways were then
suggested to be playing a role in the immunomodulating effects
caused by each specific dose of UVA in C57BL/6 mice.
Real-time RT-PCR confirmation of candidate genes
Primers used in this study were designed using the PCR simulation
program Primer3 (Whitehead Institute for Biomedical Research,
Cambridge, MA). Forward and reverse primers are shown in
Supplementary Table 13. BLASTN searches confirmed the total
gene specificity of the nucleotide sequences chosen for the primers.
Real-time RT-PCR using 2 platinum SYBR Green qPCR SuperMix-
UDB (Invitrogen) was carried out on a Rotor-Gene RG-3000 PCR
machine using Rotor-Gene 6.0 software for analysis (Corbett
Research, NSW, Australia). Each experiment was repeated six times
using six mice for each unirradiated control and UV-irradiated
group. Data obtained from the six replicate values were pooled. For
each real-time RT-PCR experiment the unirradiated control and UV-
irradiated group were normalized to the housekeeping gene HPRT.
For data analysis the 2(-Delta Delta C(T)) method was used (Livak
and Schmittgen, 2001). For statistical analysis, a Kolmogorov–Smirn-
off test determined that the data obtained from the six biological
replicates was normally distributed. An unpaired Student’s t-test was
then used with Po0.05 compared with the unirradiated control mice
(0 UV) being regarded as significant.
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